Thermo Fisher Scientific Inc. (TSX:TMO)

Market Cap	263.83B -20.4%
Revenue (ttm)	61.09B +3.9%
Net Income	9.19B +5.8%
EPS	24.32 +7.3%
Shares Out	n/a
PE Ratio	28.70
Forward PE	21.02
Dividend	0.06 (0.34%)
Ex-Dividend Date	Dec 15, 2025

Volume	7,008
Average Volume	4,729
Open	18.47
Previous Close	18.51
Day's Range	18.29 - 18.64
52-Week Range	14.22 - 23.30
Beta	n/a
RSI	30.24
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Laboratory Analytical Instruments
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: TMO

Financial Performance

In 2025, Thermo Fisher Scientific's revenue was $44.56 billion, an increase of 3.91% compared to the previous year's $42.88 billion. Earnings were $6.70 billion, an increase of 5.82%.

Financial numbers in USD